On Thursday, December 18, 2025, former President Donald Trump signed an executive order reclassifying marijuana from a Schedule I to a Schedule III drug. This change is expected to relax regulations surrounding the substance.
The reclassification marks a significant shift in federal policy regarding marijuana, which has long been classified as a Schedule I drug, indicating a high potential for abuse and no accepted medical use. The new Schedule III designation suggests that marijuana may have accepted medical uses and is less tightly regulated.
This executive order follows a series of recent developments in U.S. politics, including discussions surrounding NATO and other international matters. For more on related coverage, see recent developments regarding U.S. foreign policy.
The implications of this executive order on state laws and the broader cannabis industry remain to be seen.

Image for Trump signs executive order reclassifying marijuana to schedule 3





